Monitoring troponin-I levels can be significantly improved with innovative microchip biosensors, providing rapid and accurate readings.
The study indicates a strong correlation between microchip biosensor performance and established troponin-I concentration metrics, supporting its application in clinical settings.
Assessment using molecular imprinting technology facilitates enhanced specificity in detecting troponin-I levels compared to traditional methods.
This innovative biomarker approach may enable timely diagnosis, but further validation in larger cohorts is necessary.